Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)35797-35798
Number of pages2
JournalOncotarget
Volume9
Issue number88
DOIs
StatePublished - Nov 9 2018
Externally publishedYes

Keywords

  • AR-V7
  • eltanexor
  • prostate cancer
  • selective inhibitors of nuclear export
  • selinexor

Cite this